Merseybio Portfolio
AsterTherix
AsterTherix is a new drug discovery company exploiting IP developed by its founders at the University of Liverpool.
AsterTherix has developed a pathway-based screening system, Theraseer™. Using this screeing platform AsterTherix is developing novel therapeutics that simultaneously impact upon multiple interacting pathways. The early focus of the company is on HSP90.
AsterTherix is seeking partnerships for screening programmes, technology development and product development.
AsterTherix is seeking investment to support their in-house drug discovery programme.
For further information email: cward@merseybio.com
back to portfolio
AsterTherix
AsterTherix is a new drug discovery company exploiting IP developed by its founders at the University of Liverpool.
AsterTherix has developed a pathway-based screening system, Theraseer™. Using this screeing platform AsterTherix is developing novel therapeutics that simultaneously impact upon multiple interacting pathways. The early focus of the company is on HSP90.
AsterTherix is seeking partnerships for screening programmes, technology development and product development.
AsterTherix is seeking investment to support their in-house drug discovery programme.
For further information email: cward@merseybio.com
back to portfolio |
|
|
|
|
|
|
|
|